Pediatric Hematology specialists at the Alabama Center for Childhood Cancer and Blood Disorders, a program of the University of Alabama at Birmingham (UAB) and Children’s of Alabama, diagnose and treat bleeding disorders and non-cancer blood diseases such as hemophilia, von Willebrand disease, sickle cell disease, thalassemia, and other anemias. The nationally recognized, federally funded Comprehensive Hemophilia Treatment Center provides care for more than 200 patients with bleeding disorders, including hemophilia and von Willebrand disease. Patients attending our clinics receive multi-specialty care, allowing access to several vital health care providers during a single visit. Research at UAB in bleeding disorders is helping patients live their lives without the worries of a life threatening bleed.
Our Center provides care for more than 1,000 infants, children and adolescent patients with sickle cell disease throughout the state of Alabama. Educating patients and parents about sickle cell disease is vital to our philosophy of care. Our staff has created nationally recognized educational videos for parents starting at their first visit and our educational initiatives continue to adolescents as we prepare them for transition to adult care providers. UAB is a nationally recognized academic center conducting research to help prevent complications of disease and to find a cure. This research has led to reductions in life limiting strokes during childhood and painful events that previously limited patient’s lives.
Patients with rare blood disorders are also cared for at the Alabama Center for Childhood Cancer and Blood Disorders. With access to life-saving bone marrow transplantation, the Center offers patients the unique opportunity to be cured of their disease at an early age.